Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,730
-160 (-1.35%)
At close: Feb 20, 2026
Market Cap132.46B +73.3%
Revenue (ttm)620.44B -1.9%
Net Income67.54B
EPS5,328.78
Shares Out11.29M
PE Ratio2.29
Forward PEn/a
Dividend100.00 (0.86%)
Ex-Dividend DateMar 30, 2026
Volume32,555
Average Volume51,776
Open11,890
Previous Close11,890
Day's Range11,330 - 11,890
52-Week Range5,750 - 17,170
Beta0.30
RSI42.96
Earnings DateFeb 6, 2026

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 72
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

Financial Statements